Search Results - "Carrillo, Maria C"

Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population-based perspective by Baumgart, Matthew, Snyder, Heather M, Carrillo, Maria C, Fazio, Sam, Kim, Hye, Johns, Harry

“…Abstract An estimated 47 million people worldwide are living with dementia in 2015, and this number is projected to triple by 2050. In the absence of a…”
Get full text

The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease by Hansson, Oskar, Edelmayer, Rebecca M., Boxer, Adam L., Carrillo, Maria C., Mielke, Michelle M., Rabinovici, Gil D., Salloway, Stephen, Sperling, Reisa, Zetterberg, Henrik, Teunissen, Charlotte E.

“…Blood‐based markers (BBMs) have recently shown promise to revolutionize the diagnostic and prognostic work‐up of Alzheimer's disease (AD), as well as to…”
Get full text

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease by Jack, Clifford R., Bennett, David A., Blennow, Kaj, Carrillo, Maria C., Dunn, Billy, Haeberlein, Samantha Budd, Holtzman, David M., Jagust, William, Jessen, Frank, Karlawish, Jason, Liu, Enchi, Molinuevo, Jose Luis, Montine, Thomas, Phelps, Creighton, Rankin, Katherine P., Rowe, Christopher C., Scheltens, Philip, Siemers, Eric, Snyder, Heather M., Sperling, Reisa, Elliott, Cerise, Masliah, Eliezer, Ryan, Laurie, Silverberg, Nina

“…In 2011, the National Institute on Aging and Alzheimer's Association created separate diagnostic recommendations for the preclinical, mild cognitive…”
Get full text

Research priorities to reduce the global burden of dementia by 2025 by Shah, Hiral, MD, Albanese, Emiliano, Prof, Duggan, Cynthia, PhD, Rudan, Igor, PhD, Langa, Kenneth M, Prof, Carrillo, Maria C, PhD, Chan, Kit Yee, PhD, Joanette, Yves, PhD, Prince, Martin, Prof, Rossor, Martin, Prof, Saxena, Shekhar, MD, Snyder, Heather M, PhD, Sperling, Reisa, MD, Varghese, Mathew, Prof, Wang, Huali, MD, Wortmann, Marc, Master of Law, Dua, Tarun, Dr

“…Summary At the First WHO Ministerial Conference on Global Action Against Dementia in March, 2015, 160 delegates, including representatives from 80 WHO Member…”
Get full text

Neuropsychiatric symptoms in Alzheimer’s disease by Lyketsos, Constantine G, Carrillo, Maria C, Ryan, J. Michael, Khachaturian, Ara S, Trzepacz, Paula, Amatniek, Joan, Cedarbaum, Jesse, Brashear, Robert, Miller, David S

“…Abstract Neuropsychiatric symptoms (NPS) are core features of Alzheimer’s disease and related dementias. Once thought to emerge primarily in people with…”
Get full text

The case for low-level BACE1 inhibition for the prevention of Alzheimer disease by McDade, Eric, Voytyuk, Iryna, Aisen, Paul, Bateman, Randall J., Carrillo, Maria C., De Strooper, Bart, Haass, Christian, Reiman, Eric M., Sperling, Reisa, Tariot, Pierre N., Yan, Riqiang, Masters, Colin L., Vassar, Robert, Lichtenthaler, Stefan F.

“…Alzheimer disease (AD) is the most common cause of dementia in older individuals (>65 years) and has a long presymptomatic phase. Preventive therapies for AD…”
Get full text

Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer's disease by Shaw, Leslie M., Arias, Jalayne, Blennow, Kaj, Galasko, Douglas, Molinuevo, Jose Luis, Salloway, Stephen, Schindler, Suzanne, Carrillo, Maria C., Hendrix, James A., Ross, April, Illes, Judit, Ramus, Courtney, Fifer, Sheila

“…The Alzheimer's Association convened a multidisciplinary workgroup to develop appropriate use criteria to guide the safe and optimal use of the lumbar puncture…”
Get full text

The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease by Albert, Marilyn S, DeKosky, Steven T, Dickson, Dennis, Dubois, Bruno, Feldman, Howard H, Fox, Nick C, Gamst, Anthony, Holtzman, David M, Jagust, William J, Petersen, Ronald C, Snyder, Peter J, Carrillo, Maria C, Thies, Bill, Phelps, Creighton H

“…Abstract The National Institute on Aging and the Alzheimer’s Association charged a workgroup with the task of developing criteria for the symptomatic…”
Get full text

Vascular contributions to cognitive impairment and dementia including Alzheimer's disease by Snyder, Heather M, Corriveau, Roderick A, Craft, Suzanne, Faber, James E, Greenberg, Steven M, Knopman, David, Lamb, Bruce T, Montine, Thomas J, Nedergaard, Maiken, Schaffer, Chris B, Schneider, Julie A, Wellington, Cheryl, Wilcock, Donna M, Zipfel, Gregory J, Zlokovic, Berislav, Bain, Lisa J, Bosetti, Francesca, Galis, Zorina S, Koroshetz, Walter, Carrillo, Maria C

“…Abstract Scientific evidence continues to demonstrate the linkage of vascular contributions to cognitive impairment and dementia such as Alzheimer's disease…”
Get full text

Sex biology contributions to vulnerability to Alzheimer's disease: A think tank convened by the Women's Alzheimer's Research Initiative by Snyder, Heather M, Asthana, Sanjay, Bain, Lisa, Brinton, Roberta, Craft, Suzanne, Dubal, Dena B, Espeland, Mark A, Gatz, Margaret, Mielke, Michelle M, Raber, Jacob, Rapp, Peter R, Yaffe, Kristine, Carrillo, Maria C

“…Abstract More than 5 million Americans are living with Alzheimer's disease (AD) today, and nearly two-thirds of Americans with AD are women. This sex…”
Get full text

Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association by Johnson, Keith A, Minoshima, Satoshi, Bohnen, Nicolaas I, Donohoe, Kevin J, Foster, Norman L, Herscovitch, Peter, Karlawish, Jason H, Rowe, Christopher C, Carrillo, Maria C, Hartley, Dean M, Hedrick, Saima, Pappas, Virginia, Thies, William H

“…Abstract Positron emission tomography (PET) of brain amyloid β is a technology that is becoming more available, but its clinical utility in medical practice…”
Get full text

Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease by Jack, Clifford R, Albert, Marilyn S, Knopman, David S, McKhann, Guy M, Sperling, Reisa A, Carrillo, Maria C, Thies, Bill, Phelps, Creighton H

“…Abstract Background Criteria for the clinical diagnosis of Alzheimer's disease (AD) were established in 1984. A broad consensus now exists that these criteria…”
Get full text

The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease by McKhann, Guy M, Knopman, David S, Chertkow, Howard, Hyman, Bradley T, Jack, Clifford R, Kawas, Claudia H, Klunk, William E, Koroshetz, Walter J, Manly, Jennifer J, Mayeux, Richard, Mohs, Richard C, Morris, John C, Rossor, Martin N, Scheltens, Philip, Carrillo, Maria C, Thies, Bill, Weintraub, Sandra, Phelps, Creighton H

“…Abstract The National Institute on Aging and the Alzheimer’s Association charged a workgroup with the task of revising the 1984 criteria for Alzheimer’s…”
Get full text

National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease by Hyman, Bradley T, Phelps, Creighton H, Beach, Thomas G, Bigio, Eileen H, Cairns, Nigel J, Carrillo, Maria C, Dickson, Dennis W, Duyckaerts, Charles, Frosch, Matthew P, Masliah, Eliezer, Mirra, Suzanne S, Nelson, Peter T, Schneider, Julie A, Thal, Dietmar Rudolf, Thies, Bill, Trojanowski, John Q, Vinters, Harry V, Montine, Thomas J

“…Abstract A consensus panel from the United States and Europe was convened recently to update and revise the 1997 consensus guidelines for the neuropathologic…”
Get full text

Alzheimer's disease: The next frontier—Special Report 2017 by Karlawish, Jason, Jack, Clifford R, Rocca, Walter A, Snyder, Heather M, Carrillo, Maria C

“…Abstract In the history of medicine, one means to progress is when we make the decision that our assumptions and definitions of disease are no longer…”
Get full text

Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease by Sperling, Reisa A, Aisen, Paul S, Beckett, Laurel A, Bennett, David A, Craft, Suzanne, Fagan, Anne M, Iwatsubo, Takeshi, Jack, Clifford R, Kaye, Jeffrey, Montine, Thomas J, Park, Denise C, Reiman, Eric M, Rowe, Christopher C, Siemers, Eric, Stern, Yaakov, Yaffe, Kristine, Carrillo, Maria C, Thies, Bill, Morrison-Bogorad, Marcelle, Wagster, Molly V, Phelps, Creighton H

“…Abstract The pathophysiological process of Alzheimer’s disease (AD) is thought to begin many years before the diagnosis of AD dementia. This long “preclinical”…”
Get full text

Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association by Johnson, Keith A, Minoshima, Satoshi, Bohnen, Nicolaas I, Donohoe, Kevin J, Foster, Norman L, Herscovitch, Peter, Karlawish, Jason H, Rowe, Christopher C, Carrillo, Maria C, Hartley, Dean M, Hedrick, Saima, Pappas, Virginia, Thies, William H

“…Positron emission tomography (PET) of brain amyloid β is a technology that is becoming more available, but its clinical utility in medical practice requires…”
Get full text

rPOP: Robust PET-only processing of community acquired heterogeneous amyloid-PET data by Iaccarino, Leonardo, La Joie, Renaud, Koeppe, Robert, Siegel, Barry A., Hillner, Bruce E., Gatsonis, Constantine, Whitmer, Rachel A., Carrillo, Maria C., Apgar, Charles, Camacho, Monica R., Nosheny, Rachel, Rabinovici, Gil D.

“…The reference standard for amyloid-PET quantification requires structural MRI (sMRI) for preprocessing in both multi-site research studies and clinical trials…”
Get full text

Impact of Alzheimer's association support and engagement in the AD/ADRD research community through the COVID‐19 pandemic and beyond by Meyers, Emily A., Sexton, Claire, Snyder, Heather M., Carrillo, Maria C.

“…Introduction The WHO estimates that 55 million people worldwide have dementia and this number is expected to increase to 139 million by 2050. Founded in 1980,…”
Get full text

Neuropsychiatric signs and symptoms of Alzheimer's disease: New treatment paradigms by Lanctôt, Krista L., Amatniek, Joan, Ancoli-Israel, Sonia, Arnold, Steven E., Ballard, Clive, Cohen-Mansfield, Jiska, Ismail, Zahinoor, Lyketsos, Constantine, Miller, David S., Musiek, Erik, Osorio, Ricardo S., Rosenberg, Paul B., Satlin, Andrew, Steffens, David, Tariot, Pierre, Bain, Lisa J., Carrillo, Maria C., Hendrix, James A., Jurgens, Heidi, Boot, Brendon

“…Neuropsychiatric symptoms (NPSs) are hallmarks of Alzheimer's disease (AD), causing substantial distress for both people with dementia and their caregivers,…”
Get full text